Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
1
17%
Ph phase_2
2
33%
Ph not_applicable
1
17%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1
Not yet recruiting1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
N/A1 (25.0%)

Trials by Status

withdrawn117%
not_yet_recruiting117%
recruiting117%
completed233%
active_not_recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
recruiting

Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.

NCT06906601
not_yet_recruitingphase_1

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

NCT07217990
active_not_recruitingnot_applicable

Persistent Organic Pollutants and Breast Cancers (POPCASE)

NCT02890095
completed

Body Awareness and Functionality in Lymphedema

NCT06036173
completedphase_2

Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance

NCT01614210
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06906601

Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.

Recruiting
NCT07217990Phase 1

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Not Yet Recruiting
NCT02890095Not Applicable

Persistent Organic Pollutants and Breast Cancers (POPCASE)

Active Not Recruiting
NCT06036173

Body Awareness and Functionality in Lymphedema

Completed
NCT01614210Phase 2

Preoperative Window of Endocrine Therapy Provides Information to Increase Compliance

Completed
NCT02338531Phase 2

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6